AG

Anil Gerard Dsouza

Director Director DIN 03528949
DIN 03528949 First appointment Jun 2011 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2011
Shareholding value Locked Premium profile

About Anil Gerard Dsouza

Data last updated:

Anil Gerard Dsouza has 15 years in corporate governance. Formerly with 1 company, such as Zydus Hospira Oncology Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03528949
Primary Designation Director
First Appointment 16 Jun 2011
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director16 Jun 20112005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zydus Hospira Oncology Private Limited
Premium access

Shareholding and investment profile for Anil Gerard Dsouza

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Gerard Dsouza

Anil Gerard Dsouza has 15 years in corporate governance. Formerly with 1 company, such as Zydus Hospira Oncology Private Limited. Engaged in General Business. Contributes to corporate operations.

Anil Gerard Dsouza is associated with 0 companies as a director.

Anil Gerard Dsouza has expertise in General Business.

Anil Gerard Dsouza has 15 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available